News + Filings Transactions
|
Stampacchia Otello
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/22/2022 | Kronos Bio, Inc. | KRON | Grant | Stock Option (Right to Buy) | 34k | $3.53 | $120k | | 06/22/2022 |
| 06/09/2022 | Ikena Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $4.85 | $65.1k | | 06/09/2022 |
| 12/21/2021 | Ikena Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $14.92 | $200.2k | | 12/21/2021 |
| 06/22/2021 | Kronos Bio, Inc. | KRON | Grant | Stock Option (Right to Buy) | 20.6k | $24.18 | $498.1k | | 06/22/2021 |
| 03/30/2021 | Ikena Oncology, Inc. | | Grant | Common Stock | 450k | $16.00 | $7.2M | By Omega Fund VI, L.P. | 03/30/2021 |
| 03/30/2021 | Ikena Oncology, Inc. | | Conversion | Common Stock | 1.8M | $0.00 | $0 | By Omega Fund VI, L.P. | 03/30/2021 |
| 03/30/2021 | Ikena Oncology, Inc. | | Conversion | Series B Preferred Stock | 12.9M | $0.00 | $0 | By Omega Fund VI, L.P. | 03/30/2021 |
| 01/11/2021 | Omega Alpha SPAC | | Purchase | | 501k | $10.00 | $5M | By Omega Alpha Management (0001831897) | 01/11/2021 |
| 12/21/2020 | Ikena Oncology, Inc. | | Grant | Series B Preferred Stock | 12.9M | $1.40 | $18M | By Omega Fund VI, L.P. | 03/30/2021 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 1.6M | $0.00 | $0 | By Omega Fund V, LP | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 1.4M | $0.00 | $0 | By Omega Fund V, LP | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 366.3k | $16.15 | $5.9M | By Omega Fund V, LP | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Purchase | Common Stock | 450k | $19.00 | $8.6M | By Omega Fund V, LP | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Series Seed Preferred Stock | 1.5M | $0.00 | $0 | By Omega Fund V, LP | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Series A Preferred Stock | 1.3M | $0.00 | $0 | By Omega Fund V, LP | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Convertible Promissory Note | 0 | $16.15 | $0 | By Omega Fund V, LP | 10/14/2020 |
| 06/18/2020 | Morphic Holding, Inc. | MORF | Grant | Director Stock Option (right to buy) | 12k | $22.96 | $275.5k | | 06/18/2020 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Conversion | Series B Preferred Stock | 2M | $0.00 | $0 | By Omega Fund V, L.P. | 07/01/2019 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Conversion | Series A Preferred Stock | 857.5k | $0.00 | $0 | By Omega Fund V, L.P. | 07/01/2019 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Purchase | Common Stock | 133.3k | $15.00 | $2M | By Omega Fund V, L.P. | 07/01/2019 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Conversion | Common Stock | 2M | $0.00 | $0 | By Omega Fund V, L.P. | 07/01/2019 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Conversion | Common Stock | 857.5k | $0.00 | $0 | By Omega Fund V, L.P. | 07/01/2019 |
| 06/10/2019 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (right to buy) | 23.5k | $19.54 | $459.2k | | 06/10/2019 |
| 02/09/2010 | MICROMET, INC. | MITI | Sale | Common Stock | 105k | $8.15 | $855.8k | By Fund | 02/05/2010 |
| 02/08/2010 | MICROMET, INC. | MITI | Sale | Common Stock | 133k | $8.19 | $1.1M | By Fund | 02/05/2010 |
| 02/05/2010 | MICROMET, INC. | MITI | Sale | Common Stock | 22.5k | $8.08 | $181.9k | By Fund | 02/05/2010 |
|